» Articles » PMID: 21707111

Crystallographic and Kinetic Evidence of Allostery in a Trypsin-like Protease

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2011 Jun 29
PMID 21707111
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Protein allostery is based on the existence of multiple conformations in equilibrium linked to distinct functional properties. Although evidence of allosteric transitions is relatively easy to identify by functional studies, structural detection of a pre-existing equilibrium between alternative conformations remains challenging even for textbook examples of allosteric proteins. Kinetic studies show that the trypsin-like protease thrombin exists in equilibrium between two conformations where the active site is either collapsed (E*) or accessible to substrate (E). However, structural demonstration that the two conformations exist in the same enzyme construct free of ligands has remained elusive. Here we report the crystal structure of the thrombin mutant N143P in the E form, which complements the recently reported structure in the E* form, and both the E and E* forms of the thrombin mutant Y225P. The side chain of W215 moves 10.9 Å between the two forms, causing a displacement of 6.6 Å of the entire 215-217 segment into the active site that in turn opens or closes access to the primary specificity pocket. Rapid kinetic measurements of p-aminobenzamidine binding to the active site confirm the existence of the E*-E equilibrium in solution for wild-type and the mutants N143P and Y225P. These findings provide unequivocal proof of the allosteric nature of thrombin and lend strong support to the recent proposal that the E*-E equilibrium is a key property of the trypsin fold.

Citing Articles

Dynamic allostery in thrombin-a review.

Komives E Front Mol Biosci. 2023; 10:1200465.

PMID: 37457835 PMC: 10339233. DOI: 10.3389/fmolb.2023.1200465.


Structure-mechanics statistical learning uncovers mechanical relay in proteins.

Raj N, Click T, Yang H, Chu J Chem Sci. 2022; 13(13):3688-3696.

PMID: 35432911 PMC: 8966636. DOI: 10.1039/d1sc06184d.


How Thrombomodulin Enables W215A/E217A Thrombin to Cleave Protein C but Not Fibrinogen.

Peacock R, McGrann T, Zaragoza S, Komives E Biochemistry. 2022; 61(2):77-84.

PMID: 34978431 PMC: 9427096. DOI: 10.1021/acs.biochem.1c00635.


The active site region plays a critical role in Na binding to thrombin.

Pelc L, Koester S, Kukla C, Chen Z, Di Cera E J Biol Chem. 2021; 298(1):101458.

PMID: 34861239 PMC: 8695361. DOI: 10.1016/j.jbc.2021.101458.


Conformational Plasticity-Rigidity Axis of the Coagulation Factor VII Zymogen Elucidated by Atomistic Simulations of the N-Terminally Truncated Factor VIIa Protease Domain.

Madsen J, Olsen O Biomolecules. 2021; 11(4).

PMID: 33917935 PMC: 8068379. DOI: 10.3390/biom11040549.


References
1.
Krishnan V, Xu Y, Macon K, Volanakis J, Narayana S . The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement. J Mol Biol. 2007; 367(1):224-33. PMC: 1868468. DOI: 10.1016/j.jmb.2006.12.039. View

2.
Dickinson C, Kelly C, Ruf W . Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci U S A. 1996; 93(25):14379-84. PMC: 26140. DOI: 10.1073/pnas.93.25.14379. View

3.
Banner D, Darcy A, Chene C, Winkler F, Guha A, Konigsberg W . The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 1996; 380(6569):41-6. DOI: 10.1038/380041a0. View

4.
Rohr K, Selwood T, Marquardt U, Huber R, Schechter N, Bode W . X-ray structures of free and leupeptin-complexed human alphaI-tryptase mutants: indication for an alpha-->beta-tryptase transition. J Mol Biol. 2006; 357(1):195-209. DOI: 10.1016/j.jmb.2005.12.037. View

5.
Evans S, Olson S, SHORE J . p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases. J Biol Chem. 1982; 257(6):3014-7. View